Human Liver Macrophage Subsets Defined by CD32

Xia Wu1, Nicole Hollingshead1, Jessica Roberto1

  • 1Departments of Pathology, University of Washington Medical Center, Seattle, WA, United States.

Frontiers in Immunology
|October 26, 2020
PubMed

Insights

Researchers identified two distinct subsets of human liver myeloid cells, differing in surface markers and gene expression. These subsets suggest unique roles in T cell tolerance and may challenge current definitions of liver macrophages and dendritic cells.

Area of Science:

  • Immunology
  • Cell Biology
  • Hepatology

Background:

  • Human liver myeloid cells, including Kupffer cells (liver macrophages), are not fully characterized.
  • Previous single-cell RNA sequencing studies suggest heterogeneity within liver macrophage populations.

Purpose of the Study:

  • To define and characterize distinct subsets of macrophage-like cells in human liver.
  • To investigate the potential functional differences between these subsets, particularly in T cell interactions.

Main Methods:

  • Analysis of dissociated human liver tissue using CD11b and CD68 markers.
  • Fluorescence-activated cell sorting (FACS) based on CD32 expression to isolate subsets.
  • Gene expression analysis (qRT-PCR) to identify subset characteristics and functions.

Main Results:

  • Two distinct subsets of CD11b+CD68+ myeloid cells were identified in the human liver.
  • These subsets exhibited differential expression of surface markers and genes related to T cell activation and immunosuppression.
  • One subset expressed CD1C and CD11c, markers typically associated with classical dendritic cells.

Conclusions:

  • The human liver contains at least two distinct populations of myeloid cells with macrophage characteristics.
  • These subsets may play different roles in regulating T cell responses and maintaining immune tolerance.
  • Current criteria for distinguishing macrophages from dendritic cells in the human liver may require re-evaluation.